Resonance Specialties Limited has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026. The company reported a significant improvement in profitability for the fiscal year, driven by higher income and efficient cost management. The Board of Directors meeting, held on May 14, 2026, approved the results, which were reviewed by the audit committee prior to approval.

Full-Year Financial Performance

For the financial year ended March 31, 2026, Resonance Specialties posted a net profit of ₹1,039.58 lakh, representing a 58.30% increase compared to ₹656.62 lakh in the previous year. Total income for the year stood at ₹9,188.93 lakh, up from ₹7,878.69 lakh in the prior year. Revenue from operations grew to ₹9,024.75 lakh from ₹7,780.66 lakh year-on-year. The company's basic and diluted earnings per share (EPS) for the year improved to ₹9.01 from ₹5.69 in the previous year.

The following table summarises the key financial highlights for FY26:

Quarterly Performance

In the fourth quarter ended March 31, 2026, Resonance Specialties reported a net profit of ₹459.56 lakh, compared to ₹305.75 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter was ₹2,447.71 lakh, slightly higher than ₹2,420.17 lakh in the same period last year. Total income for the quarter stood at ₹2,521.34 lakh against ₹2,429.54 lakh in the year-ago period, while total expenses were managed at ₹1,922.18 lakh compared to ₹2,010.00 lakh previously.

Balance Sheet Highlights

As at March 31, 2026, Resonance Specialties reported total assets of ₹9,246.73 lakh, up from ₹7,555.03 lakh as at March 31, 2025. Total equity stood at ₹7,323.77 lakh compared to ₹6,402.17 lakh in the prior year. Current assets increased to ₹6,691.59 lakh from ₹5,221.04 lakh, driven by higher inventories of ₹3,430.04 lakh and investments of ₹1,157.40 lakh. Non-current assets rose to ₹2,555.14 lakh from ₹2,333.99 lakh, reflecting capital work-in-progress of ₹367.73 lakh.

Cash Flow Summary

For the year ended March 31, 2026, net cash flow from operating activities stood at ₹1,731.72 lakh, a significant turnaround from a cash outflow of ₹1,242.01 lakh in the previous year. Net cash used in investment activities was ₹1,489.65 lakh, compared to an inflow of ₹355.99 lakh in the prior year, primarily on account of mutual fund purchases of ₹1,133.45 lakh and fixed asset purchases of ₹374.12 lakh. Net cash used in financing activities was ₹246.59 lakh, including dividend paid of ₹115.44 lakh. Cash and cash equivalents at the end of the year stood at ₹17.97 lakh.

Segment Performance and Dividend

Resonance Specialties operates primarily in the Chemical Manufacturing segment. Geographically, revenue from operations outside India increased significantly to ₹5,355.06 lakh in FY26 from ₹3,411.08 lakh in the prior year, while revenue from India stood at ₹3,669.69 lakh, compared to ₹4,369.58 lakh previously.

The board of directors has recommended a dividend of ₹1 per share (10%) for the financial year 2025-26, subject to shareholder approval at the forthcoming Annual General Meeting. The company has fixed Tuesday, July 28, 2026, as the record date to determine member entitlement for the dividend. Additionally, M/s Kailash Chand Jain & Co. have been re-appointed as Statutory Auditors for a further period of five years, subject to shareholder approval, and have issued an audit report with an unmodified opinion on the financial results for the year ended March 31, 2026.

Resonance Specialties Limited has announced that its Board of Directors will meet on Thursday, May 14, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026, and to recommend a dividend for the said financial year.

Key Agenda Items

The Board meeting will primarily focus on two significant matters:

• Consideration and approval of audited financial results for Q4FY26 and FY26
• Recommendation of dividend for the financial year ended March 31, 2026

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has informed that the trading window for dealing in the securities of the company by insiders remains closed. The closure period commenced from the close of business hours on March 31, 2026, and will continue until 48 hours after the declaration of the company's audited financial results for the fourth quarter and financial year ended March 31, 2026.

Company Details

The intimation was submitted through online filing on April 30, 2026, and was digitally signed by Vaibhavi Shah, Company Secretary of Resonance Specialties Limited.